l carnitine and diabetes The effects of L-carnitine supplementation on cardiovascular risk factors in participants with impaired glucose tolerance diabetes: a systematic review and dose–response meta-analysis | Diabetology & Metabolic Syndrome Role of carnitine in disease

Xie Z, Zheng G, Liang Z, et al

Transient opening of the BBB: Therapeutics injected endovascularly can improve their homing to the brain by temporarily disrupting the BBB

anti-inflammatory Primary clinical goal GH optimization

The present study has been supported by Institute of Health Carlos III of the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund (ERDF): PI12/02529, PI15/01206, CP15/00103, Red de Reacciones Adversas a Alergenos y Farmacos RD12/0013/0001, RD12/0013/0003 and RD12/0013/0008, RD09/0076/00112 for the Biobank network and PT13/0010/0006 for the Biobank platform) and by State Secretariat for Research, Development and Innovation of the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund (ERDF): MINECO SAF2012-36519, SAF2015-68590-R/FEDER and CTQ2013-41339-P)

So, while a temporary rise in blood sugar post-administration is expected, it does not automatically equate to long-term insulin resistance